FK 448: RN given refers to methanesulfonate; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 174763 |
SCHEMBL ID | 1082568 |
MeSH ID | M0122371 |
Synonym |
---|
fk-448 |
fk 448 |
1-naphthalenecarboxylic acid, 1,2,3,4-tetrahydro-, 4-((4-(1-methylethyl)-1-piperazinyl)carbonyl)phenyl ester, monomethanesulfonate |
85858-77-1 |
1-naphthalenecarboxylic acid, 1,2,3,4-tetrahydro-, 4-((4-(1-methylethyl)-1-piperazinyl)carbonyl)phenyl ester, methanesulfonate |
4-(4-isopropylpiperazinocarbonyl)phenyl 1,2,3,4-tetrahydro-1-naphthoate methanesulfonate |
89703-10-6 |
SCHEMBL1082568 |
methanesulfonic acid--4-[4-(propan-2-yl)piperazine-1-carbonyl]phenyl 1,2,3,4-tetrahydronaphthalene-1-carboxylate (1/1) |
DTXSID101008947 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (20.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |